2022 | March / April 2022

Pharma 4.0 manufacturing optimization using eData

by cyb2025

STEPHEN M. WING
EMD Millipore, Bedford, USA, Life Science Business of Merck KGaA, Darmstadt, Germany

ABSTRACT

Various digital technologies are currently available to help biopharmaceutical and pharmaceutical manufacturers drive significant process improvements. There are numerous areas where process automation and simplification can be enabled using electronic data (eData) from key raw material suppliers. This article describes some current use cases in which the manufacturer’s analytical capabilities are enhanced using a standard eData platform, and also explores future opportunities to optimize other critical parts of the production process including logistics-related applications.

DATA ENABLES PHARMA 4.0
With the advancement of Pharma 4.0, there is the potential to implement significant business improvements using digital tools and capabilities. The availability of technologies, such as cloud-based platforms, artificial intelligence (AI), machine learning (ML), advanced process analytics, etc., enables drug manufacturers to better understand, monitor, and control their production processes. However, these technologies are simply tools and a thorough understanding of specific applications and use cases is an absolute necessity in selecting and implementing the right technologies for a particular situation.

ABOUT THE AUTHOR

Stephen Wing is the Head of Analytical & Logistical Services responsible for developing innovative digital solutions, enabling improvements across the entire biopharma manufacturing process. He joined EMD Millipore in 2019 and has held product and business development roles in Aerospace, Energy, Digital, and Life Sciences. He has an MS in Engineering Management from Northeastern University and BSME from Boston University.

Login